Endogenous analgesia, dependence, and latent pain sensitization

Current Topics in Behavioral Neurosciences

Volumn 20, Issue , 2014, Pages 283-325

  Taylor, Bradley K ^a   Corder, Gregory ^a,b,c  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Addiction; Adenylyl cyclase; Analgesia; Central sensitization; Constitutive activity; Dependence; Latent sensitization; NMDA receptor; Opioid; Pain; Postoperative pain; Stress

Indexed keywords

ADENYLATE CYCLASE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALOXONE;

ACTION POTENTIAL; ANALGESIA; ARTICLE; DRUG DEPENDENCE; DRUG SENSITIZATION; GENE EXPRESSION; HUMAN; INCIDENCE; NOCICEPTIVE PAIN; NONHUMAN; OPIATE ADDICTION; PAIN INTENSITY; PRIORITY JOURNAL; SPINAL CORD; SYNAPTIC TRANSMISSION; TISSUE INJURY;

EID: 84922064374     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2014_351     Document Type: Article

References (218)

1. Abe T, Matsumura S, Katano T, Mabuchi T, Takagi K, Xu L, Yamamoto A, Hattori K, Yagi T, Watanabe M, Nakazawa T, Yamamoto T, Mishina M, Nakai Y, Ito S (2005) Fyn kinasemediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain. Eur J Neurosci 22:1445-1454
2. Aicher SA, Punnoose A, Goldberg A (2000) [micro]-Opioid receptors often colocalize with the substance P receptor (NK1) in the trigeminal dorsal horn. J Neurosci 20:4345-4354
3. Ainsworth L, Budelier K, Clinesmith M, Fiedler A, Landstrom R, Leeper BJ, Moeller L, Mutch S, O'Dell K, Ross J, Radhakrishnan R, Sluka KA (2006) Transcutaneous electrical nerve stimulation (TENS) reduces chronic hyperalgesia induced by muscle inflammation. Pain 120:182-187
4. Aley KO, Messing RO, Mochly-Rosen D, Levine JD (2000) Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci 20:4680-4685
5. Alkaitis MS, Solorzano C, Landry RP, Piomelli D, DeLeo JA, Romero-Sandoval EA (2010) Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain. PLoS ONE 5:e10891
6. Aloisi AM, Lupo C, Carli G (1993) Effects of formalin-induced pain on exploratory behaviour in rabbits. NeuroReport 4:739-742
7. Anderson WS, Sheth RN, Bencherif B, Frost JJ, Campbell JN (2002) Naloxone increases pain induced by topical capsaicin in healthy human volunteers. Pain 99:207-216
8. Asiedu MN, Tillu DV, Melemedjian OK, Shy A, Sanoja R, Bodell B, Ghosh S, Porreca F, Price TJ (2011) Spinal protein kinase M zeta underlies the maintenance mechanism of persistent nociceptive sensitization. J Neurosci 31:6646-6653
9. Baba H, Ji RR, Kohno T, Moore KA, Ataka T, Wakai A, Okamoto M, Woolf CJ (2003) Removal of GABAergic inhibition facilitates polysynaptic A fiber-mediated excitatory transmission to the superficial spinal dorsal horn. Mol Cell Neurosci 24:818-830
10. Back SK, Lee J, Hong SK, Na HS (2006) Loss of spinal mu-opioid receptor is associated with mechanical allodynia in a rat model of peripheral neuropathy. Pain 123:117-126
11. Banks WA, Kastin AJ (1990) Peptide transport systems for opiates across the blood-brain barrier. Am J Physiol 259:E1-10
12. Bardoni R, Tawfik VL, Wang D, Francois A, Solorzano C, Shuster SA, Choudhury P, Betelli C, Cassidy C, Smith K, de Nooij JC, Mennicken F, O'Donnell D, Kieffer BL, Woodbury CJ, Basbaum AI, MacDermott AB, Scherrer G (2014) Delta opioid receptors presynaptically regulate cutaneous mechanosensory neuron input to the spinal cord dorsal horn. Neuron 81:1312-1327
13. Basbaum AI, Bautista DM, Scherrer G, Julius D (2009) Cellular and molecular mechanisms of pain. Cell 139:267-284
14. Basbaum AI, Fields HL (1984) Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7:309-338
15. Benedetti F, Arduino C, Amanzio M (1999) Somatotopic activation of opioid systems by target directed expectations of analgesia. J Neuroscience 19:3639-3648
16. Benrath J, Brechtel C, Martin E, Sandkuhler J (2004) Low doses of fentanyl block central sensitization in the rat spinal cord in vivo. Anesthesiology 100:1545-1551
17. Besse D, Lombard MC, Zajac JM, Roques BP, Besson JM (1990) Pre-and postsynaptic distribution of mu, delta and kappa opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res 521:15-22
18. Bilsky EJ, Bernstein RN, Wang Z, Sadee W, Porreca F (1996) Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. J Pharmacol Exp Ther 277:484-490
19. Brennum J, Kaiser F, Dahl JB (2001) Effect of naloxone on primary and secondary hyperalgesia induced by the human burn injury model. Acta Anaesthesiol Scand 45:954-960
20. Bruehl S, Chung OY, Chont M (2010) Chronic pain-related changes in endogenous opioid analgesia: a case report. Pain 148:167-171
21. Bruehl S, Chung OY, Ward P, Johnson B (2004) Endogenous opioids and chronic pain intensity: interactions with level of disability. Clin J Pain 20:283-292
22. Buchsbaum MS, Davis GC, Bunney WE (1977) Naloxone alters pain perception and somatosensory evoked potentials in humans. Nature 270:620
23. Cabanero D, Campillo A, Celerier E, Romero A, Puig MM (2009) Pronociceptive effects of remifentanil in a mouse model of postsurgical pain effect of a second surgery. Anesthesiology 111:1334-1345
24. Calza L, Pozza M, Arletti R, Manzini E, Hokfelt T (2000) Long-lasting regulation of galanin, opioid, and other peptides in dorsal root ganglia and spinal cord during experimental polyarthritis. Exp Neurol 164:333-343
25. Campillo A, Cabanero D, Romero A, Garcia-Nogales P, Puig MM (2011) Delayed postoperative latent pain sensitization revealed by the systemic administration of opioid antagonists in mice. Eur J Pharmacol 657:89-96
26. Cesselin F, Bourgoin S, Clot AM, Hamon M, Le Bars D (1989) Segmental release of Metenkephalin-like material from the spinal cord of rats, elicited by noxious thermal stimuli. Brain Res 484:71-77
27. Chacur M, Milligan ED, Gazda LS, Armstrong C, Wang H, Tracey KJ, Maier SF, Watkins LR (2001) A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats. Pain 94:231-244
28. Chai B, Guo W, Wei F, Dubner R, Ren K (2012) Trigeminal-rostral ventromedial medulla circuitry is involved in orofacial hyperalgesia contralateral to tissue injury. Mol Pain 8:78
29. Chang HM, Berde CB, Holz GGt, Steward GF, Kream RM (1989) Sufentanil, morphine, metenkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions. Anesthesiology 70:672-677
30. Chavkin C, McLaughlin JP, Celver JP (2001) Regulation of opioid receptor function by chronic agonist exposure: constitutive activity and desensitization. Mol Pharmacol 60:20-25
31. Chetkovich DM, Sweatt JD (1993) nMDA receptor activation increases cyclic AMP in area CA1 of the hippocampus via calcium/calmodulin stimulation of adenylyl cyclase. J Neurochem 61:1933-1942
32. Chillingworth NL, Morham SG, Donaldson LF (2006) Sex differences in inflammation and inflammatory pain in cyclooxygenase-deficient mice. Am J Physiol Regul Integr Comp Physiol 291:R327-R334
33. Christie MJ (2008) Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol 154:384-396
34. Christie MJ, Chesher GB (1982) Physical dependence on physiologically released endogenous opiates. Life Sci 30:1173-1177
35. Colantuoni C, Rada P, McCarthy J, Patten C, Avena NM, Chadeayne A, Hoebel BG (2002) Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence. Obes Res 10:478-488
36. Connor M, Traynor J (2010) Constitutively active mu-opioid receptors. Methods Enzymol 484:445-469
37. Conti AC, Maas JW Jr, Muglia LM, Dave BA, Vogt SK, Tran TT, Rayhel EJ, Muglia LJ (2007) Distinct regional and subcellular localization of adenylyl cyclases type 1 and 8 in mouse brain. Neuroscience 146:713-729
38. Corder G, Doolen S, Donahue RR, Winter MK, Jutras BL, He Y, Hu X, Wieskopf JS, Mogil JS, Storm DR, Wang ZJ, McCarson KE, Taylor BK (2013) Constitutive mu-opioid receptor activity leads to long-term endogenous analgesia and dependence. Science 341:1394-1399
39. Corder GF (2013) Injury establishes constitutive mu-opioid receptor activity leading to lasting endogenous analgesia and dependence. Dissertation, University of Kentucky
40. Costa T, Herz A (1989) Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci U S A 86:7321-7325
41. De Felice M, Sanoja R, Wang R, Vera-Portocarrero L, Oyarzo J, King T, Ossipov MH, Vanderah TW, Lai J, Dussor GO, Fields HL, Price TJ, Porreca F (2011) Engagement of descending inhibition from the rostral ventromedial medulla protects against chronic neuropathic pain. Pain 152:2701-2709
42. Dirks J, Fredensborg BB, Christensen D, Fomsgaard JS, Flyger H, Dahl JB (2002a) A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. Anesthesiology 97:560-564
43. Dirks J, Petersen KL, Dahl JB (2003) The heat/capsaicin sensitization model: a methodologic study. J Pain 4:122-128
44. Dirks J, Petersen KL, Rowbotham MC, Dahl JB (2002b) Gabapentin suppresses cutaneous hyperalgesia following heat-capsaicin sensitization. Anesthesiology 97:102-107
45. Divin MF, Bradbury FA, Carroll FI, Traynor JR (2009) Neutral antagonist activity of naltrexone and 6beta-naltrexol in naive and opioid-dependent C6 cells expressing a mu-opioid receptor. Br J Pharmacol 156:1044-1053
46. Doolen S, Blake CB, Smith BN, Taylor BK (2012) Peripheral nerve injury increases glutamateevoked calcium mobilization in adult spinal cord neurons. Mol Pain 8:56
47. Drdla R, Gassner M, Gingl E, Sandkuhler J (2009) Induction of synaptic long-term potentiation after opioid withdrawal. Science 325:207-210
48. Duggan AW, North RA (1983) Electrophysiology of opioids. Pharmacol Rev 35:219-281
49. El-Sobky A, Dostrovsky JO, Wall PD (1976) Lack of effect of naloxone on pain perception in humans. Nature 263:783-784
50. Erbs E, Faget L, Scherrer G, Matifas A, Filliol D, Vonesch JL, Koch M, Kessler P, Hentsch D, Birling MC, Koutsourakis M, Vasseur L, Veinante P, Kieffer BL, Massotte D (2014) A mudelta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks. Brain Struct Funct (in press)
51. Fell GL, Robinson KC, Mao J, Woolf CJ, Fisher DE (2014) Skin beta-Endorphin Mediates Addiction to UV Light. Cell 157:1527-1534
52. Ferrari LF, Bogen O, Levine JD (2010) Nociceptor subpopulations involved in hyperalgesic priming. Neuroscience 165:896-901
53. Frid M, Singer G, Oei T, Rana C (1981) Reactions to ischemic pain: interactions between individual, situational and naloxone effects. Psychopharmacology 73:116-119
54. Fuchs PN, Roza C, Sora I, Uhl G, Raja SN (1999) Characterization of mechanical withdrawal responses and effects of mu-, delta-and kappa-opioid agonists in normal and mu-opioid receptor knockout mice. Brain Res 821:480-486
55. Gabra BH, Kessler FK, Ritter JK, Dewey WL, Smith FL (2007) Decrease in N-methyl-D-aspartic acid receptor-NR2B subunit levels by intrathecal short-hairpin RNA blocks group I metabotropic glutamate receptor-mediated hyperalgesia. J Pharmacol Exp Ther 322:186-194
56. Gao YJ, Ji RR (2010a) Light touch induces ERK activation in superficial dorsal horn neurons after inflammation: involvement of spinal astrocytes and JNK signaling in touch-evoked central sensitization and mechanical allodynia. J Neurochem 115:505-514
57. Gao YJ, Ji RR (2010b) Targeting astrocyte signaling for chronic pain. Neurother J Am Soc Exp Neurother 7:482-493
58. Glaum SR, Miller RJ, Hammond DL (1994) Inhibitory actions of delta 1-, delta 2-, and mu-opioid receptor agonists on excitatory transmission in lamina II neurons of adult rat spinal cord. J Neurosci 14:4965-4971
59. Goff JR, Burkey AR, Goff DJ, Jasmin L (1998) Reorganization of the spinal dorsal horn in models of chronic pain: correlation with behaviour. Neuroscience 82:559-574
60. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA (2000) Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. J Neurosci 20:RC110
61. Gracely RH, Dubner R, Wolskee PJ, Deeter WR (1983) Placebo and naloxone can alter postsurgical pain by separate mechanisms. Nature 306:264-265
62. Green PG, Chen X, Alvarez P, Ferrari LF, Levine JD (2011) Early-life stress produces muscle hyperalgesia and nociceptor sensitization in the adult rat. Pain 152:2549-2556
63. Grevert P, Goldstein A (1978) Endorphins: naloxone fails to alter experimental pain or mood in humans. Science 199:1093
64. Guan Y, Yuan F, Carteret AF, Raja SN (2010) A partial L5 spinal nerve ligation induces a limited prolongation of mechanical allodynia in rats: an efficient model for studying mechanisms of neuropathic pain. Neurosci Lett 471:43-47
65. Guo W, Zou S, Guan Y, Ikeda T, Tal M, Dubner R, Ren K (2002) Tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord during the development and maintenance of inflammatory hyperalgesia. J Neurosci 22:6208-6217
66. Hatashita S, Sekiguchi M, Kobayashi H, Konno S, Kikuchi S (2008) Contralateral neuropathic pain and neuropathology in dorsal root ganglion and spinal cord following hemilateral nerve injury in rats. Spine 33:1344-1351
67. He Y, Tian X, Hu X, Porreca F, Wang ZJ (2012) Negative reinforcement reveals non-evoked ongoing pain in mice with tissue or nerve injury. J Pain 13:598-607
68. Heinke B, Gingl E, Sandkuhler J (2011) Multiple targets of mu-opioid receptor-mediated presynaptic inhibition at primary afferent Adelta-and C-fibers. J Neurosci 31:1313-1322
69. Herz A, Millan MJ (1988) Endogenous opioid peptides in the descending control of nociceptive responses of spinal dorsal horn neurons. Prog Brain Res 77:263-273
70. Hori Y, Endo K, Takahashi T (1992) Presynaptic inhibitory action of enkephalin on excitatory transmission in superficial dorsal horn of rat spinal cord. J Physiol 450:673-685
71. Hucho T, Levine JD (2007) Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron 55:365-376
72. Hurley RW, Hammond DL (2000) The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation. J Neurosci 20:1249-1259
73. Hurley RW, Hammond DL (2001) Contribution of endogenous enkephalins to the enhanced analgesic effects of supraspinal mu opioid receptor agonists after inflammatory injury. J Neurosci 21:2536-2545
74. Iadarola MJ, Brady LS, Draisci G, Dubner R (1988) Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain 35:313-326
75. Iadarola MJ, Tang J, Costa E, Yang HY (1986) Analgesic activity and release of [MET5] enkephalin-Arg6-Gly7-Leu8 from rat spinal cord in vivo. Eur J Pharmacol 121:39-48
76. Ikeda H, Stark J, Fischer H, Wagner M, Drdla R, Jager T, Sandkuhler J (2006) Synaptic amplifier of inflammatory pain in the spinal dorsal horn. Science 312:1659-1662
77. Illing S, Mann A, Schulz S (2014) Heterologous regulation of agonist-independent mu-opioid receptor phosphorylation by protein kinase C. Br J Pharmacol 171:1330-1340
78. Jeftinija S (1988) Enkephalins modulate excitatory synaptic transmission in the superficial dorsal horn by acting at mu-opioid receptor sites. Brain Res 460:260-268
79. Jessell TM, Iversen LL (1977) Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature 268:549-551
80. Ji RR (2004) Peripheral and central mechanisms of inflammatory pain, with emphasis on MAP kinases. Current Drug Targets-Inflamm Allergy 3:299-303
81. Ji RR, Baba H, Brenner GJ, Woolf CJ (1999) Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 2:1114-1119
82. Ji RR, Gereau RW IV, Malcangio M, Strichartz GR (2009) MAP kinase and pain. Brain Res Rev 60:135-148
83. Ji RR, Kohno T, Moore KA, Woolf CJ (2003) Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 26:696-705
84. Ji RR, Xu ZZ, Strichartz G, Serhan CN (2011) Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci 34:599-609
85. Ji RR, Zhang Q, Law PY, Low HH, Elde R, Hokfelt T (1995) Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenaninduced inflammation. J Neurosci 15:8156-8166
86. Joseph EK, Levine JD (2010) Hyperalgesic priming is restricted to isolectin B4-positive nociceptors. Neuroscience 169:431-435
87. Jungkunz G, Engel RR, King UG, Kuss HJ (1983) Endogenous opiates increase pain tolerance after stress in humans. Psychiatry Res 8:13-18
88. Kaur M, Liguori A, Lang W, Rapp SR, Fleischer AB Jr, Feldman SR (2006) Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners. J Am Acad Dermatol 54:709-711
89. Kenakin T (2001) Inverse, protean, and ligand-selective agonism: matters of receptor conformation. FASEB J Official Publ Fed Am Soc Exp Biol 15:598-611
90. Kenakin T (2004) Principles: receptor theory in pharmacology. Trends Pharmacol Sci 25:186-192
91. Kenakin T (2007) Functional selectivity through protean and biased agonism: who steers the ship? Mol Pharmacol 72:1393-1401
92. Kern D, Plantevin F, Bouhassira D (2008) Effects of morphine on the experimental illusion of pain produced by a thermal grill. Pain 139:653-659
93. Kest B, Palmese CA, Hopkins E, Adler M, Juni A, Mogil JS (2002) Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Neuroscience 115:463-469
94. Kim SH, Chung JM (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50:355-363
95. King T, Vera-Portocarrero L, Gutierrez T, Vanderah TW, Dussor G, Lai J, Fields HL, Porreca F (2009) Unmasking the tonic-aversive state in neuropathic pain. Nat Neurosci 12:1364-1366
96. Kohno T, Kumamoto E, Higashi H, Shimoji K, Yoshimura M (1999) Actions of opioids on excitatory and inhibitory transmission in substantia gelatinosa of adult rat spinal cord. J Physiol 518(Pt 3):803-813
97. Koltzenburg M, Wall PD, McMahon SB (1999) Does the right side know what the left is doing? [see comments]. Trends Neurosci 22:122-127
98. Kondo I, Marvizon JC, Song B, Salgado F, Codeluppi S, Hua XY, Yaksh TL (2005) Inhibition by spinal mu-and delta-opioid agonists of afferent-evoked substance P release. J Neurosci 25:3651-3660
99. Koob GF, Maldonado R, Stinus L (1992) Neural substrates of opiate withdrawal. Trends Neurosci 15:186-191
100. Krapivinsky G, Krapivinsky L, Manasian Y, Ivanov A, Tyzio R, Pellegrino C, Ben-Ari Y, ßClapham DE, Medina I (2003) The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. Neuron 40:775-784
101. Lam H, Maga M, Pradhan A, Evans CJ, Maidment NT, Hales TG, Walwyn W (2011) Analgesic tone conferred by constitutively active mu opioid receptors in mice lacking beta-arrestin 2. Mol Pain 7:24
102. Lane-Ladd SB, Pineda J, Boundy VA, Pfeuffer T, Krupinski J, Aghajanian GK, Nestler EJ (1997) CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 17:7890-7901
103. Latremoliere A, Woolf CJ (2009) Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 10:895-926
104. Law PY, Erickson-Herbrandson LJ, Zha QQ, Solberg J, Chu J, Sarre A, Loh HH (2005) Heterodimerization of mu-and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions. J Biol Chem 280:11152-11164
105. Le Roy C, Laboureyras E, Gavello-Baudy S, Chateauraynaud J, Laulin JP, Simonnet G (2011) Endogenous opioids released during non-nociceptive environmental stress induce latent pain sensitization Via a NMDA-dependent process. J Pain 12:1069-1079
106. Leurs R, Smit MJ, Alewijnse AE, Timmerman H (1998) Agonist-independent regulation of constitutively active G-protein-coupled receptors. Trends Biochem Sci 23:418-422
107. Lever IJ, Pezet S, McMahon SB, Malcangio M (2003) The signaling components of sensory fiber transmission involved in the activation of ERK MAP kinase in the mouse dorsal horn. Molecular and cellular neurosciences 24:259-270
108. Levine JD, Gordon NC, Fields HL (1979) Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature 278:740-741
109. Levine JD, Gordon NC, Jones RT, Fields HL (1978) The narcotic antagonist naloxone enhances clinical pain. Nature 272:826-827
110. Li S, Lee ML, Bruchas MR, Chan GC, Storm DR, Chavkin C (2006) Calmodulin-stimulated adenylyl cyclase gene deletion affects morphine responses. Mol Pharmacol 70:1742-1749
111. Li XY, Ko HG, Chen T, Descalzi G, Koga K, Wang H, Kim SS, Shang Y, Kwak C, Park SW, Shim J, Lee K, Collingridge GL, Kaang BK, Zhuo M (2010) Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex. Science 330:1400-1404
112. Lian B, Vera-Portocarrero L, King T, Ossipov MH, Porreca F (2010) Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity. Brain Res 1358:64-70
113. Liauw J, Wu LJ, Zhuo M (2005) Calcium-stimulated adenylyl cyclases required for long-term potentiation in the anterior cingulate cortex. J Neurophysiol 94:878-882
114. Liu JG, Prather PL (2001) Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. Mol Pharmacol 60:53-62
115. Liu JG, Ruckle MB, Prather PL (2001) Constitutively active mu-opioid receptors inhibit adenylyl cyclase activity in intact cells and activate G-proteins differently than the agonist [D-Ala2, NMePhe4, Gly-ol5]enkephalin. J Biol Chem 276:37779-37786
116. Lu HC, She WC, Plas DT, Neumann PE, Janz R, Crair MC (2003) Adenylyl cyclase I regulates AMPA receptor trafficking during mouse cortical 'barrel' map development. Nat Neurosci 6:939-947
117. Luo C, Seeburg PH, Sprengel R, Kuner R (2008) Activity-dependent potentiation of calcium signals in spinal sensory networks in inflammatory pain states. Pain 140:358-367
118. Lutz PE, Kieffer BL (2013) Opioid receptors: distinct roles in mood disorders. Trends Neurosci 36:195-206
119. Mann A, Illing S, Miess E, Schulz S (2014) Different Mechanisms of Homologous and Heterologous mu-Opioid Receptor Phosphorylation. British J Pharmacol (in press)
120. Mansour A, Fox CA, Akil H, Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18:22-29
121. Marker CL, Lujan R, Loh HH, Wickman K (2005) Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu-and delta-but not kappaopioids. J Neurosci 25:3551-3559
122. Matsumoto M, Xie W, Ma L, Ueda H (2008) Pharmacological switch in Abeta-fiber stimulationinduced spinal transmission in mice with partial sciatic nerve injury. Mol Pain 4:25
123. Mazei-Robison MS, Nestler EJ (2012) Opiate-induced molecular and cellular plasticity of ventral tegmental area and locus coeruleus catecholamine neurons. Cold Spring Harb Perspect Med 2: a012070
124. Meye FJ, van Zessen R, Smidt MP, Adan RA, Ramakers GM (2012) Morphine withdrawal enhances constitutive mu-opioid receptor activity in the ventral tegmental area. J Neurosci 32:16120-16128
125. Millan MJ (2002) Descending control of pain. Prog Neurobiol 66:355-474
126. Millan MJ, Morris BJ, Colpaert FC, Herz A (1987) A model of chronic pain in the rat: highresolution neuroanatomical approach identifies alterations in multiple opioid systems in the periaqueductal grey. Brain Res 416:349-353
127. Morley JE, Levine AS (1980) Stress-Induced Eating Is Mediated through Endogenous Opiates. Science 209:1259-1261
128. Mousa SA, Machelska H, Schafer M, Stein C (2002) Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J Neuroimmunol 126:5-15
129. Navani DM, Sirohi S, Madia PA, Yoburn BC (2011) The role of opioid antagonist efficacy and constitutive opioid receptor activity in the opioid withdrawal syndrome in mice. Pharmacol Biochem Behav 99:671-675
130. Nestler EJ, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278:58-63
131. Nielsen MD, Chan GC, Poser SW, Storm DR (1996) Differential regulation of type I and type VIII Ca2 +-stimulated adenylyl cyclases by Gi-coupled receptors in vivo. J Biol Chem 271:33308-33316
132. Noble F, Coric P, Turcaud S, Fournie-Zaluski MC, Roques BP (1994) Assessment of physical dependence after continuous perfusion into the rat jugular vein of the mixed inhibitor of enkephalin-degrading enzymes, RB 101. Eur J Pharmacol 253:283-287
133. Noguchi K, Dubner R, Ruda MA (1992) Preproenkephalin mRNA in spinal dorsal horn neurons is induced by peripheral inflammation and is co-localized with Fos and Fos-related proteins. Neuroscience 46:561-570
134. Ossipov MH, Dussor GO, Porreca F (2010) Central modulation of pain. J Clin Investig 120:3779-3787
135. Paoletti P, Bellone C, Zhou Q (2013) NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14:383-400
136. Parada CA, Vivancos GG, Tambeli CH, Cunha FQ, Ferreira SH (2003) Activation of presynaptic NMDA receptors coupled to NaV1.8-resistant sodium channel C-fibers causes retrograde mechanical nociceptor sensitization. Proc Natl Acad Sci USA 100:2923-2928
137. Pereira MP, Werner MU, Ringsted TK, Rowboth MC, Taylor BK, Dahl JB (2013) Does naloxone reinstate secondary hyperalgesia in humans after resolution of a burn injury? A placebocontrolled, double-blind, randomized, cross-over study. PloS One 8:e64608
138. Porreca F, Ossipov MH, Gebhart GF (2002) Chronic pain and medullary descending facilitation. Trends Neurosci 25:319-325
139. Posner J, Burke CA (1985) The effects of naloxone on opiate and placebo analgesia in healthy volunteers. Psychopharmacology 87:468-472
140. Qiu S, Chen T, Koga K, Guo YY, Xu H, Song Q, Wang JJ, Descalzi G, Kaang BK, Luo JH, Zhuo M, Zhao MG (2013) An increase in synaptic NMDA receptors in the insular cortex contributes to neuropathic pain. Sci Sig 6:ra34
141. Raehal KM, Lowery JJ, Bhamidipati CM, Paolino RM, Blair JR, Wang D, Sadee W, Bilsky EJ (2005) In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice. J Pharmacol Exp Ther 313:1150-1162
142. Ravn P, Frederiksen R, Skovsen AP, Christrup LL, Werner MU (2012) Prediction of pain sensitivity in healthy volunteers. J Pain Res 5:313-326
143. Ravn P, Secher EL, Skram U, Therkildsen T, Christrup LL, Werner MU (2013) Morphine-and buprenorphine-induced analgesia and antihyperalgesia in a human inflammatory pain model: a double-blind, randomized, placebo-controlled, five-arm crossover study. J Pain Res 6:23-38
144. Rees H, Sluka KA, Lu Y, Westlund KN, Willis WD (1996) Dorsal root reflexes in articular afferents occur bilaterally in a chronic model of arthritis in rats. J Neurophysiol 76:4190-4193
145. Reichling DB, Levine JD (2009) Critical role of nociceptor plasticity in chronic pain. Trends Neurosci 32:611-618
146. Rivat C, Laboureyras E, Laulin JP, Le Roy C, Richebe P, Simonnet G (2007) Non-nociceptive environmental stress induces hyperalgesia, not analgesia, in pain and opioid-experienced rats. Neuropsychopharmacology 32:2217-2228
147. Rivat C, Laulin JP, Corcuff JB, Celerier E, Pain L, Simonnet G (2002) Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: prevention by the N-methyl-D-aspartate receptor antagonist ketamine. Anesthesiology 96:381-391
148. Ruscheweyh R, Wilder-Smith O, Drdla R, Liu XG, Sandkuhler J (2011) Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy. Mol Pain 7:20
149. Sadee W, Wang D, Bilsky EJ (2005) Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities. Life Sci 76:1427-1437
150. Sally EJ, Xu H, Dersch CM, Hsin LW, Chang LT, Prisinzano TE, Simpson DS, Giuvelis D, Rice KC, Jacobson AE, Cheng K, Bilsky EJ, Rothman RB (2010) Identification of a novel "almost neutral" micro-opioid receptor antagonist in CHO cells expressing the cloned human muopioid receptor. Synapse 64:280-288
151. Sandkuhler J, Gruber-Schoffnegger D (2012) Hyperalgesia by synaptic long-term potentiation (LTP): an update. Curr Opin Pharmacol 12:18-27
152. Schepers RJ, Mahoney JL, Gehrke BJ, Shippenberg TS (2008a) Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation. Pain 138:423-439
153. Schepers RJ, Mahoney JL, Shippenberg TS (2008b) Inflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociception. Pain 136:320-330
154. Scherrer G, Imamachi N, Cao YQ, Contet C, Mennicken F, O'Donnell D, Kieffer BL, Basbaum AI (2009) Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 137:1148-1159
155. Schneider SP, Eckert WA, Light AR (1998) Opioid-activated postsynaptic, inward rectifying potassium currents in whole cell recordings in substantia gelatinosa neurons. J Neurophysiol 80:2954-2962
156. Schoell ED, Bingel U, Eippert F, Yacubian J, Christiansen K, Andresen H, May A, Buechel C (2010) The effect of opioid receptor blockade on the neural processing of thermal stimuli. PLoS One 5:e12344
157. Schweinhardt P, Sauro KM, Bushnell MC (2008) Fibromyalgia: a disorder of the brain? Neurosci Rev J Bringing Neurobiol Neurol Psychiatry 14:415-421
158. Seifert R, Wenzel-Seifert K (2002) Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn-Schmiedeberg's Arch Pharmacol 366:381-416
159. Seltzer Z, Dubner R, Shir Y (1990) A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43:205-218
160. Sevcik MA, Jonas BM, Lindsay TH, Halvorson KG, Ghilardi JR, Kuskowski MA, Mukherjee P, Maggio JE, Mantyh PW (2006) Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancer. Gastroenterology 131:900-910
161. Shoblock JR, MaidmentNT(2006) Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice. Neuropsychopharmacology 31:171-177 (official publication of the American College of Neuropsychopharmacology)
162. Shoblock JR, Maidment NT (2007) Enkephalin release promotes homeostatic increases in constitutively active mu opioid receptors during morphine withdrawal. Neuroscience 149:642-649
163. Sindreu CB, Scheiner ZS, Storm DR (2007) Ca2 +-stimulated adenylyl cyclases regulate ERKdependent activation of MSK1 during fear conditioning. Neuron 53:79-89
164. Sirohi S, Dighe SV, Madia PA, Yoburn BC (2009) The relative potency of inverse opioid agonists and a neutral opioid antagonist in precipitated withdrawal and antagonism of analgesia and toxicity. J Pharmacol Exp Ther 330:513-519
165. Skjelbred P, Lokken P (1983) Effects of naloxone on post-operative pain and steroid-induced analgesia. Br J Clin Pharmacol 15:221-226
166. Sluka KA, Kalra A, Moore SA (2001) Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 24:37-46
167. Solway B, Bose SC, Corder G, Donahue RR, Taylor BK (2011) Tonic inhibition of chronic pain by neuropeptide Y. Proc Natl Acad Sci USA 108:7224-7229
168. Song B, Marvizon JC (2003a) Dorsal horn neurons firing at high frequency, but not primary afferents, release opioid peptides that produce micro-opioid receptor internalization in the rat spinal cord. J Neurosci 23:9171-9184
169. Song B, Marvizon JC (2003b) Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids. J Neurosci 23:1847-1858
170. Spike RC, Puskar Z, Sakamoto H, Stewart W, Watt C, Todd AJ (2002) MOR-1-immunoreactive neurons in the dorsal horn of the rat spinal cord: evidence for nonsynaptic innervation by substance P-containing primary afferents and for selective activation by noxious thermal stimuli. Eur J Neurosci 15:1306-1316
171. Stacher G, Abatzi TA, Schulte F, Schneider C, Stacher-Janotta G, Gaupmann G, Mittelbach G, Steinringer H (1988) Naloxone does not alter the perception of pain induced by electrical and thermal stimulation of the skin in healthy humans. Pain 34:271-276
172. Stanfa L, Dickenson A (1995) Spinal opioid systems in inflammation. Inflamm Res 44:231-241
173. Stanfa LC, Sullivan AF, Dickenson AH (1992) Alterations in neuronal excitability and the potency of spinal mu, delta and kappa opioids after carrageenan-induced inflammation. Pain 50:345-354
174. Stein C, Lang LJ (2009) Peripheral mechanisms of opioid analgesia. Curr Opin Pharmacol 9:3-8
175. Suarez-Roca H, Maixner W (1992) Morphine produces a multiphasic effect on the release of substance P from rat trigeminal nucleus slices by activating different opioid receptor subtypes. Brain Res 579:195-203
176. Sufka KJ (1994) Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain. Pain 58:355-366
177. Summer GJ, Puntillo KA, Miaskowski C, Green PG, Levine JD (2007) Burn injury pain: the continuing challenge. J Pain 8:533-548
178. Tambeli CH, Levine JD, Gear RW (2009) Centralization of noxious stimulus-induced analgesia (NSIA) is related to activity at inhibitory synapses in the spinal cord. Pain 143:228-232
179. Taylor BK, Peterson MA, Basbaum AI (1997) Continuous intravenous infusion of naloxone does not change behavioral, cardiovascular, or inflammatory responses to subcutaneous formalin in the rat. Pain 69:171-177
180. Terman GW, Eastman CL, Chavkin C (2001) Mu opiates inhibit long-term potentiation induction in the spinal cord slice. J Neurophysiol 85:485-494
181. Tillu DV, Gebhart GF, Sluka KA (2008) Descending facilitatory pathways from the RVM initiate and maintain bilateral hyperalgesia after muscle insult. Pain 136:331-339
182. Torsney C (2011) Inflammatory pain unmasks heterosynaptic facilitation in lamina I neurokinin 1 receptor-expressing neurons in rat spinal cord. J Neurosci 31:5158-5168
183. Torsney C, MacDermott AB (2006) Disinhibition opens the gate to pathological pain signaling in superficial neurokinin 1 receptor-expressing neurons in rat spinal cord. J Neurosci 26:1833-1843
184. Trafton JA, Basbaum AI (2004) [d-Ala2, N-MePhe4, Gly-ol5]enkephalin-induced internalization of the micro opioid receptor in the spinal cord of morphine tolerant rats. Neuroscience 125:541-543
185. Walker EA, Sterious SN (2005) Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence. Br J Pharmacol 145:975-983
186. Walwyn W, Evans CJ, Hales TG (2007) Beta-arrestin2 and c-Src regulate the constitutive activity and recycling of mu opioid receptors in dorsal root ganglion neurons. J Neurosci 27:5092-5104
187. Wang D, Raehal KM, Bilsky EJ, Sadee W (2001a) Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence. J Neurochem 77:1590-1600
188. Wang D, Raehal KM, Lin ET, Lowery JJ, Kieffer BL, Bilsky EJ, Sadee W (2004) Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence. J Pharmacol Exp Ther 308:512-520
189. Wang D, Sun X, Sadee W (2007) Different effects of opioid antagonists on mu-, delta-, and kappaopioid receptors with and without agonist pretreatment. J Pharmacol Exp Ther 321:544-552
190. Wang GD, Zhuo M (2002) Synergistic enhancement of glutamate-mediated responses by serotonin and forskolin in adult mouse spinal dorsal horn neurons. J Neurophysiol 87:732-739
191. Wang H, Xu H, Wu LJ, Kim SS, Chen T, Koga K, Descalzi G, Gong B, Vadakkan KI, Zhang X, Kaang BK, Zhuo M (2011) Identification of an adenylyl cyclase inhibitor for treating neuropathic and inflammatory pain. Sci Transl Med 3:65ra63
192. Wang Z, Bilsky EJ, Porreca F, Sadee W (1994) Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci 54:PL339-350
193. Wang Z, Gardell LR, Ossipov MH, Vanderah TW, Brennan MB, Hochgeschwender U, Hruby VJ, Malan TP Jr, Lai J, Porreca F (2001b) Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci 21:1779-1786
194. Wei F, Qiu CS, Kim SJ, Muglia L, Maas JW, Pineda VV, Xu HM, Chen ZF, Storm DR, Muglia LJ, Zhuo M (2002) Genetic elimination of behavioral sensitization in mice lacking calmodulinstimulated adenylyl cyclases. Neuron 36:713-726
195. Wei F, Vadakkan KI, Toyoda H, Wu LJ, Zhao MG, Xu H, Shum FW, Jia YH, Zhuo M (2006) Calcium calmodulin-stimulated adenylyl cyclases contribute to activation of extracellular signal-regulated kinase in spinal dorsal horn neurons in adult rats and mice. J Neurosci 26:851-861
196. Werner MU, Lassen B, Kehlet H (2002a) Analgesic effects of dexamethasone in burn injury. Reg Anesth Pain Med 27:254-260
197. Werner MU, Lassen B, Pedersen JL, Kehlet H (2002b) Local cooling does not prevent hyperalgesia following burn injury in humans. Pain 98:297-303
198. Werner MU, Perkins F, Holte K, Pedersen JL, Kehlet H (2001) Effects of gabapentin in acute inflammatory pain in humans. Reg Anesth Pain Med 26:322-328
199. Werner MU, Petersen KL, Rowbotham MC, Dahl JB (2013) Healthy volunteers can be phenotyped using cutaneous sensitization pain models. PLoS ONE 8:e62733
200. Weyerbacher AR, Xu Q, Tamasdan C, Shin SJ, Inturrisi CE (2010) N-Methyl-D-aspartate receptor (NMDAR) independent maintenance of inflammatory pain. Pain 148:237-246
201. Willcockson WS, Chung JM, Hori Y, Lee KH, Willis WD (1984) Effects of iontophoretically released peptides on primate spinothalamic tract cells. J Neurosci 4:741-750
202. Wong ST, Athos J, Figueroa XA, Pineda VV, Schaefer ML, Chavkin CC, Muglia LJ, Storm DR (1999) Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP. Neuron 23:787-798
203. Woolf CJ (2011) Central sensitization: implications for the diagnosis and treatment of pain. Pain 152:S2-15
204. Woolf CJ, Costigan M (1999) Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci USA 96:7723-7730
205. Woolf CJ, Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science 288:1765-1769
206. Xia ZG, Refsdal CD, Merchant KM, Dorsa DM, Storm DR (1991) Distribution of mRNA for the calmodulin-sensitive adenylate cyclase in rat brain: expression in areas associated with learning and memory. Neuron 6:431-443
207. Xu H, Partilla JS, Wang X, Rutherford JM, Tidgewell K, Prisinzano TE, Bohn LM, Rothman RB (2007) A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence. Synapse 61:166-175
208. Xu H, Wu LJ, Wang H, Zhang X, Vadakkan KI, Kim SS, Steenland HW, Zhuo M (2008) Presynaptic and postsynaptic amplifications of neuropathic pain in the anterior cingulate cortex. J Neurosci 28:7445-7453
209. Yaksh TL (1987) Opioid receptor systems and the endorphins: a review of their spinal organization. J Neurosurg 67:157-176
210. Yaksh TL, Al-Rodhan NR, Jensen TS (1988) Sites of action of opiates in production of analgesia. Prog Brain Res 77:371-394
211. Yaksh TL, Elde RP (1981) Factors governing release of methionine enkephalin-like immunoreactivity from mesencephalon and spinal cord of the cat in vivo. J Neurophysiol 46:1056-1075
212. Yoo JH, Bailey A, Borsodi A, Toth G, Matifas A, Kieffer BL, Kitchen I (2014) Knockout subtraction autoradiography: A novel ex vivo method to detect heteromers finds sparse KOP receptor/DOP receptor heterodimerization in the brain. Eur J Pharmacol 731C:1-7
213. Yoshimura M, North RA (1983) Substantia gelatinosa neurones hyperpolarized in vitro by enkephalin. Nature 305:529-530
214. Yu XM, Sessle BJ, Vernon H, Hu JW (1994) Administration of opiate antagonist naloxone induces recurrence of increased jaw muscle activities related to inflammatory irritant application to rat temporomandibular joint region. J Neurophysiol 72:1430-1433
215. Zachariou V, Liu R, LaPlant Q, Xiao G, Renthal W, Chan GC, Storm DR, Aghajanian G, Nestler EJ (2008) Distinct roles of adenylyl cyclases 1 and 8 in opiate dependence: behavioral, electrophysiological, and molecular studies. Biol Psychiatry 63:1013-1021
216. Zhuo M (2012) Targeting neuronal adenylyl cyclase for the treatment of chronic pain. Drug Discovery Today 17:573-582
217. Zhou HY, Chen SR, Chen H, Pan HL (2010) Opioid-induced long-term potentiation in the spinal cord is a presynaptic event. J Neurosci 30:4460-4466
218. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS (2001) Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293:311-315